SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na^+ Excretion Activity
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-03-20
著者
-
Matsui Kazuki
Research Center Sumitomo Pharmaceuticals Co. Ltd
-
Nariai Tetsuro
Pharmacology Research Laboratory, Dainippon Sumitomo Pharma Co., Ltd., Japan
-
Fujita Katsuya
Pharmacology Research Laboratory, Dainippon Sumitomo Pharma Co., Ltd., Japan
-
Katayama Seiji
Chemistry Research Laboratory, Dainippon Sumitomo Pharma Co., Ltd., Japan
-
Mori Masaya
Pharmacology Dainippon Sumitomo Pharma Co. Ltd.
-
Hori Seiji
Chemistry Research Laboratories Dainippon Sumitomo Pharma Co. Ltd.
-
Fujita Katsuya
Pharmacology Dainippon Sumitomo Pharma Co. Ltd.
-
Katayama Seiji
Chemistry Research Laboratories Dainippon Sumitomo Pharma Co. Ltd.
-
Matsui Kazuki
Research Planning & Management Dainippon Sumitomo Pharma Co. Ltd.
-
Nariai Tetsuro
Pharmacology Dainippon Sumitomo Pharma Co. Ltd.
関連論文
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity
- Design, Synthesis, and Structure-Activity Relationships of 3,4-Dihydropyridopyrimidin-2(1H)-one Derivatives as a Novel Class of Sodium/Calcium Exchanger Inhibitor
- Relationship between the Neuroprotective Effect of Na^+/H^+ Exchanger Inhibitor SM-20220 and the Timing of Its Administration in a Transient Middle Cerebral Artery Occlusion Model of Rats
- Effect of SMP-300, a New Na^+/H^+ Exchange Inhibitor, on Myocardial Ischemia and Experimental Angina Models in Rats
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na^+ Excretion Activity